Search

Your search keyword '"Ramjankhan F"' showing total 158 results
Start Over Author "Ramjankhan F"
158 results on '"Ramjankhan F"'

3. Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device

Author

Numan, L, Aarts, E, Ramjankhan, F, Oerlemans, MIF, van der Meer, MG, de Jonge, N, Oppelaar, AM, Kemperman, H, Asselbergs, FW, Van Laake, LW, Numan, L, Aarts, E, Ramjankhan, F, Oerlemans, MIF, van der Meer, MG, de Jonge, N, Oppelaar, AM, Kemperman, H, Asselbergs, FW, and Van Laake, LW

Abstract

BACKGROUND: Soluble suppression of tumorigenicity-2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown. Therefore, we studied the relationship between sST2 and outcome after left ventricular assist device implantation. METHODS AND RESULTS: sST2 levels of patients with a left ventricular assist device implanted between January 2015 and December 2022 were included in this observational study. The median follow-up was 25 months, during which 1573 postoperative sST2 levels were measured in 199 patients, with a median of 29 ng/mL. Survival of patients with normal and elevated preoperative levels was compared using Kaplan-Meier analysis, which did not differ significantly (P=0.22) between both groups. The relationship between postoperative sST2, survival, and right heart failure was evaluated using a joint model, which showed a significant relationship between the absolute sST2 level and mortality, with a hazard ratio (HR) of 1.20 (95% CI, 1.10– 1.130; P<0.01) and an HR of 1.22 (95% CI, 1.07–1.39; P=0.01) for right heart failure, both per 10-unit sST2 increase. The sST2 instantaneous change was not predictive for survival or right heart failure (P=0.99 and P=0.94, respectively). Multivariate joint model analysis showed a significant relationship between sST2 with mortality adjusted for NT-proBNP (N-terminal pro-B-type natriuretic peptide), with an HR of 1.19 (95% CI, 1.00–1.42; P=0.05), whereas the HR of right heart failure was not significant (1.22 [95% CI, 0.94–1.59]; P=0.14), both per 10-unit sST2 increase. CONCLUSIONS: Time-dependent postoperative sST2 predicts all-cause mortality after left ventricular assist device implantation after adjustment for NT-proBNP. Future research is warranted into possible target interventions and the optimal monitoring frequency.

Published
2024

4. FLAVOUR Study: FLow profiles And postoperative VasOplegia after continUous-flow left ventriculaR assist device implantation

Author

Kersten, BJ, Numan, L, van der Schoot, MM, de Jong, M, Ramjankhan, F, Aarts, E, Oerlemans, MIFJ, van Laake, LW, de Waal, EEC, Kersten, BJ, Numan, L, van der Schoot, MM, de Jong, M, Ramjankhan, F, Aarts, E, Oerlemans, MIFJ, van Laake, LW, and de Waal, EEC

Abstract

Abstract: This study aims to associate the incidence of postoperative vasoplegia and short-term survival to the implantation of various left ventricular assist devices differing in hemocompatibility and flow profiles. The overall incidence of vasoplegia was 25.3% (73/289 patients) and 30.3% (37/122), 25.0% (18/72), and 18.9% (18/95) in the axial flow (AXF), centrifugal flow (CF), and centrifugal flow with artificial pulse (CFAP) group, respectively. Vasoplegia was associated with longer intensive care (ICU) and hospital length of stay (LOS) and mortality. ICU and in-hospital LOS and 1-year mortality were the lowest in the CFAP group. Post hoc analysis resulted in a p-value of 0.43 between AXF and CF; 0.35 between CF and CFAP; and 0.06 between AXF and CFAP. Although there is a trend in diminished incidence of vasoplegia, pooled logistic regression using flow profile and variables that remained after feature selection showed that flow profile was not an independent predictor for postoperative vasoplegia. Graphical Abstract: (Figure presented.)

Published
2024

5. Surgical treatment of esophago-tracheobronchial fistulas after esophagectomy

Author

Cancer, MS CGO, Heelkunde Opleiding, CTC, Circulatory Health, MS Oogheelkunde, Other research (not in main researchprogram), Medische staf Anesthesiologie, Cardiologie, de Groot, E M, Kingma, B F, Goense, L, van der Kaaij, N P, Meijer, R C A, Ramjankhan, F Z, Schellekens, P A A, Braithwaite, S A, Marsman, M, van der Heijden, J J, Ruurda, J P, van Hillegersberg, R, Cancer, MS CGO, Heelkunde Opleiding, CTC, Circulatory Health, MS Oogheelkunde, Other research (not in main researchprogram), Medische staf Anesthesiologie, Cardiologie, de Groot, E M, Kingma, B F, Goense, L, van der Kaaij, N P, Meijer, R C A, Ramjankhan, F Z, Schellekens, P A A, Braithwaite, S A, Marsman, M, van der Heijden, J J, Ruurda, J P, and van Hillegersberg, R

Published
2024

6. FLAVOUR Study: FLow profiles And postoperative VasOplegia after continUous-flow left ventriculaR assist device implantation

Author

Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Kersten, BJ, Numan, L, van der Schoot, MM, de Jong, M, Ramjankhan, F, Aarts, E, Oerlemans, MIFJ, van Laake, LW, de Waal, EEC, Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Kersten, BJ, Numan, L, van der Schoot, MM, de Jong, M, Ramjankhan, F, Aarts, E, Oerlemans, MIFJ, van Laake, LW, and de Waal, EEC

Published
2024

7. Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device

Author

Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Numan, L, Aarts, E, Ramjankhan, F, Oerlemans, MIF, van der Meer, MG, de Jonge, N, Oppelaar, AM, Kemperman, H, Asselbergs, FW, Van Laake, LW, Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Numan, L, Aarts, E, Ramjankhan, F, Oerlemans, MIF, van der Meer, MG, de Jonge, N, Oppelaar, AM, Kemperman, H, Asselbergs, FW, and Van Laake, LW

Published
2024

10. PB1371 Platelet Activation with the Aeson Bioprosthetic Total Artificial Heart: Insight from Aspirin Treatment and Outcomes

Author

Smadja, D., primary, Peronino, C., additional, Jilet, L., additional, Ivak, P., additional, Pia, Y., additional, Philippe, A., additional, Latremouille, C., additional, Gustafsson, F., additional, Ramjankhan, F., additional, Roussel, J., additional, Vincentelli, A., additional, Flecher, E., additional, Gaussem, P., additional, Jansen, P., additional, and Netuka, I., additional

Published
2023
Full Text
View/download PDF

12. Surgical treatment of esophago-tracheobronchial fistulas after esophagectomy

Author

de Groot, E M, primary, Kingma, B F, additional, Goense, L, additional, van der Kaaij, N P, additional, Meijer, R C A, additional, Ramjankhan, F Z, additional, Schellekens, P A A, additional, Braithwaite, S A, additional, Marsman, M, additional, van der Heijden, J J, additional, Ruurda, J P, additional, and van Hillegersberg, R, additional

Published
2023
Full Text
View/download PDF

13. Surgical treatment of esophago-tracheobronchial fistulas after esophagectomy.

Author

Groot, E M de, Kingma, B F, Goense, L, Kaaij, N P van der, Meijer, R C A, Ramjankhan, F Z, Schellekens, P A A, Braithwaite, S A, Marsman, M, Heijden, J J van der, Ruurda, J P, and Hillegersberg, R van

Subjects
ESOPHAGECTOMY, FISTULA, MULTIPLE organ failure, FREE flaps, THORACOTOMY
Abstract

The aim of this study was to evaluate the surgical treatment of esophago-tracheobronchial fistulas (ETBFs) that occurred after esophagectomy with gastric conduit reconstruction in a tertiary referral center for esophageal surgery. All patients who underwent surgical repair for an ETBF after esophagectomy with gastric conduit reconstruction were included in a tertiary referral center. The primary outcome was successful recovery after surgical treatment for ETBF, defined as a patent airway at 90 days after the surgical fistula repair. Secondary outcomes were details on the clinical presentation, diagnostics, and postoperative course after fistula repair. Between 2007 and 2022, 14 patients who underwent surgical repair for an ETBF were included. Out of 14 patients, 9 had undergone esophagectomy with cervical anastomosis and 5 esophagectomy with intrathoracic anastomosis after which 13 patients had developed anastomotic leakage. Surgical treatment consisted of thoracotomy to cover the defect with a pericardial patch and intercostal flap in 11 patients, a patch without interposition of healthy tissue in 1 patient, and fistula repair via cervical incision with only a pectoral muscle flap in 2 patients. After surgical treatment, 12 patients recovered (86%). Mortality occurred in two patients (14%) due to multiple organ failure. This study evaluated the techniques and outcomes of surgical repair of ETBFs following esophagectomy with gastric conduit reconstruction in 14 patients. Treatment was successful in 12 patients (86%) and generally consisted of thoracotomy and coverage of the defect with a bovine pericardial patch followed by interposition with an intercostal muscle. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients

Author

Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Sub Neurobiologie van gedrag, Numan, L., Aarts, E., Ramjankhan, F., Oerlemans, M.I.F., van der Meer, M.G., de Jonge, N., Oppelaar, A.-M., Kemperman, H., Asselbergs, F.W., Van Laake, L.W., Leerstoel Klugkist, Methodology and statistics for the behavioural and social sciences, Sub Neurobiologie van gedrag, Numan, L., Aarts, E., Ramjankhan, F., Oerlemans, M.I.F., van der Meer, M.G., de Jonge, N., Oppelaar, A.-M., Kemperman, H., Asselbergs, F.W., and Van Laake, L.W.

Published
2023

17. Stroke Complications in Patients Requiring Durable Mechanical Circulatory Support Systems After Extracorporeal Life Support

Author

Saeed, D, Loforte, A, Morshuis, M, Schibilsky, D, Zimpfer, D, Riebandt, J, Pappalardo, F, Attisani, M, Rinaldi, M, Haneya, A, Ramjankhan, F, Donker, Dw, Jorde, Up, Pacini, D, Otto, W, Stein, J, Lewin, D, Jawad, K, Wieloch, R, Ayala, R, Cremer, J, Borger, Ma, Lichtenberg, A, Gummert, J, Potapov, E, Durable MCS after ECLS Study, Group., Cardiovascular and Respiratory Physiology, and TechMed Centre

Subjects
Biomaterials, 2023 OA procedure, Biomedical Engineering, Biophysics, Bioengineering, General Medicine, ECMO, ECLS, mechanical circulatory support system, stroke
Abstract

Stroke is one of the leading complications following durable mechanical circulatory support (MCS) implantation. The aim of this multicenter study was to investigate stroke complications in patients requiring durable MCS following extracorporeal life support (ECLS). Data of 11 high volume MCS centers were collected and evaluated to identify patients who underwent durable MCS implantation after ECLS support between January 2010 and August 2018. The primary outcome was stroke following durable MCS implantation. Univariate and multivariate logistic regression analyses were performed to determine predictors of stroke. Overall, 531 patients met the inclusion criteria. Only patients who were supported with continuous flow pumps were included in this study accounting for 495 patients (median age 54 years old [interquartile range 47-60]). A total of 136 patients (27%) developed postoperative stroke on device during the follow-up (48% ischemic and 52% hemorrhagic) after a median durable MCS support of 320 [32-1,000] days, accounting for 0.17 events per patient-year. Of 133 patients with known date of stroke, a total of 47 (10%) developed stroke during the first 30 days (64% ischemic and 36% hemorrhagic), and 86 patients developed stroke after 30 days (38% ischemic and 62% hemorrhagic) of durable MCS support (late stroke). Survival rate was significantly lower in patients with hemorrhagic stroke (p = 0.00091). Stroke appears to be a common complication in patients transitioned to durable MCS support after ECLS. Hemorrhagic stroke is a more common type of late stroke and is associated with inferior outcomes.

Published
2022

18. A routine intervention in a highly unusual vessel

Author

Onderzoek Vrouw Hart & Vaatziekten, Team Medisch, Circulatory Health, Medische staf Anesthesiologie, CTC, Regenerative Medicine and Stem Cells, Gasecka, A., Voskuil, M., de Waal, E. E.C., Oerlemans, M. I.F.J., Ramjankhan, F., van Laake, L. W., Kraaijeveld, A. O., Onderzoek Vrouw Hart & Vaatziekten, Team Medisch, Circulatory Health, Medische staf Anesthesiologie, CTC, Regenerative Medicine and Stem Cells, Gasecka, A., Voskuil, M., de Waal, E. E.C., Oerlemans, M. I.F.J., Ramjankhan, F., van Laake, L. W., and Kraaijeveld, A. O.

Published
2022

20. Listing criteria for heart transplantation in the Netherlands

Author

Cardiologie, Team Medisch, Circulatory Health, CTC, Regenerative Medicine and Stem Cells, de Jonge, N., Damman, K., Ramjankhan, F. Z., van der Kaaij, N. P., van den Broek, S. A.J., Erasmus, M. E., Kuijpers, M., Manintveld, O., Bekkers, J. A., Constantinescu, A. C., Brugts, J. J., Oerlemans, M. I.F., van Laake, L. W., Caliskan, K., Cardiologie, Team Medisch, Circulatory Health, CTC, Regenerative Medicine and Stem Cells, de Jonge, N., Damman, K., Ramjankhan, F. Z., van der Kaaij, N. P., van den Broek, S. A.J., Erasmus, M. E., Kuijpers, M., Manintveld, O., Bekkers, J. A., Constantinescu, A. C., Brugts, J. J., Oerlemans, M. I.F., van Laake, L. W., and Caliskan, K.

Published
2021

21. Twelve years of circulatory extracorporeal life support at the University Medical Centre Utrecht

Author

Medische Staf Intensive Care, AIOS Anesthesiologie, Medische staf Anesthesiologie, Other research (not in main researchprogram), CTC, Circulatory Health, Team Medisch, Medische Staf Spoedeisende Hulp, Trialbureau Vitale Functies, Infection & Immunity, Brain, Meuwese, C L, Hermens, J A, de Haan, M, Braithwaite, S A, Ramjankhan, F, Buijsrogge, M P, de Jonge, N, Kirkels, J H, de Jong, M, Pasma, W, Vromen-Wijsman, J L P, Kraaijeveld, A O, de Waal, E E, Torn, E, Platenkamp, M, van der Heijden, J J, Cremer, O L, van Dijk, D, Donker, D W, Medische Staf Intensive Care, AIOS Anesthesiologie, Medische staf Anesthesiologie, Other research (not in main researchprogram), CTC, Circulatory Health, Team Medisch, Medische Staf Spoedeisende Hulp, Trialbureau Vitale Functies, Infection & Immunity, Brain, Meuwese, C L, Hermens, J A, de Haan, M, Braithwaite, S A, Ramjankhan, F, Buijsrogge, M P, de Jonge, N, Kirkels, J H, de Jong, M, Pasma, W, Vromen-Wijsman, J L P, Kraaijeveld, A O, de Waal, E E, Torn, E, Platenkamp, M, van der Heijden, J J, Cremer, O L, van Dijk, D, and Donker, D W

Published
2021

23. Neurological Complications in Patients Requiring Durable VAD Systems after ECLS Support. On Behalf of ECLS- Durable MCS Study Group

Author

Saeed, D., primary, Potapov, E., additional, Loforte, A., additional, Morshuis, M., additional, Schibilsky, D., additional, Zimpfer, D., additional, Riebandt, J., additional, Pappalardo, F., additional, Attisani, M., additional, Rinaldi, M., additional, Haneya, A., additional, Ramjankhan, F., additional, Donker, D., additional, Jorde, U., additional, Stein, J., additional, Tsyganenko, D., additional, Jawad, K., additional, Wieloch, R., additional, Ayala, R., additional, Cremer, J., additional, Borger, M., additional, Lichtenberg, A., additional, and Gummert, J., additional

Published
2021
Full Text
View/download PDF

26. The role of long-term mechanical circulatory support in patients with advanced heart failure

Author

Felix, S.E.A. (S. E.A.), Jonge, N. (Nicolaas) de, Caliskan, K.C. (Kadir), Birim, O. (Ozcan), Damman, K. (Kevin), Kuijpers, M. (M.), Tops, L.F. (Laurens), Palmen, M. (Meindert), Ramjankhan, F. (Faiz), Felix, S.E.A. (S. E.A.), Jonge, N. (Nicolaas) de, Caliskan, K.C. (Kadir), Birim, O. (Ozcan), Damman, K. (Kevin), Kuijpers, M. (M.), Tops, L.F. (Laurens), Palmen, M. (Meindert), and Ramjankhan, F. (Faiz)

Abstract

In patients with end-stage heart failure, advanced therapies such as heart transplantation and long-term mechanical circulatory support (MCS) with a left ventricular assist device (LVAD) have to be considered. LVADs can be implanted as a bridge to transplantation or as an alternative to heart transplantation: destination therapy. In the Netherlands, long-term LVAD therapy is gaining importance as a result of increased prevalence of heart failure together with a low number of heart transplantations due to shortage of donor hearts. As a result, the difference between bridge to transplantation and destination therapy is becoming more artificial since, at present, most patients initially implanted as bridge to transplantation end up receiving extended LVAD therapy. Following LVAD implantation, survival after 1, 2 and 3 years is 83%, 76% and 70%, respectively. Quality of life improves substantially despite important adverse events such as device-related infection, stroke, major bleeding and right heart failure. Early referral of potential candidates for long-term MCS is of utmost importance and positively influences outcome. In this review, an overview of the indications, contraindications, patient selection, clinical outcome and optimal time of referral for long-term MCS is given.

Published
2020
Full Text
View/download PDF

27. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

Author

Felix, S E A, Ramjankhan, F Z, Buijsrogge, M P, Jacob, K A, Asselbergs, F W, Oerlemans, M I F, Kirkels, J H, van Laake, L W, Oppelaar, A M C, Suyker, W J L, de Jonge, N, Felix, S E A, Ramjankhan, F Z, Buijsrogge, M P, Jacob, K A, Asselbergs, F W, Oerlemans, M I F, Kirkels, J H, van Laake, L W, Oppelaar, A M C, Suyker, W J L, and de Jonge, N

Published
2020

28. Venoarterial extracorporeal membrane oxygenation in elective high-risk percutaneous coronary intervention: a viable option?

Author

Medische Staf Intensive Care, CTC, Circulatory Health, Team Medisch, Other research (not in main researchprogram), Meuwese, C L, Ramjankhan, F Z, Kraaijeveld, A O, Donker, D W, Medische Staf Intensive Care, CTC, Circulatory Health, Team Medisch, Other research (not in main researchprogram), Meuwese, C L, Ramjankhan, F Z, Kraaijeveld, A O, and Donker, D W

Published
2020

29. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

Author

Team Medisch, CTC, Circulatory Health, Arts Assistenten CTC, Regenerative Medicine and Stem Cells, MCS-team, Divisie Hart & Longen, Felix, S. E.A., Ramjankhan, F. Z., Buijsrogge, M. P., Jacob, K. A., Asselbergs, F. W., Oerlemans, M. I.F., Kirkels, J. H., van Laake, L. W., Oppelaar, A. M.C., Suyker, W. J.L., de Jonge, N., Team Medisch, CTC, Circulatory Health, Arts Assistenten CTC, Regenerative Medicine and Stem Cells, MCS-team, Divisie Hart & Longen, Felix, S. E.A., Ramjankhan, F. Z., Buijsrogge, M. P., Jacob, K. A., Asselbergs, F. W., Oerlemans, M. I.F., Kirkels, J. H., van Laake, L. W., Oppelaar, A. M.C., Suyker, W. J.L., and de Jonge, N.

Published
2020

34. Transition from VA-ECMO to Durable VAD Systems. Do We Need Cardiopulmonary Bypass Machine? On Behalf of ECMO-VAD Study Group

Author

Saeed, D., primary, Potapov, E.V., additional, Loforte, A., additional, Morshuis, M., additional, Schibilsky, D., additional, Zimpfer, D., additional, Riebandt, J., additional, Pappalardo, F., additional, Attisani, M., additional, Haneya, A., additional, Ramjankhan, F., additional, Donker, D., additional, Tsyganenko, D., additional, Jorde, U., additional, Jawad, K., additional, Wieloch, R., additional, Ayala, R., additional, Cremer, J., additional, Borger, M., additional, Lichtenberg, A., additional, and Gummert, J.F., additional

Published
2020
Full Text
View/download PDF

35. Implanting Durable VAD Systems in Patients on VA-ECMO: Comparing Less Invasive to Sternotomy Approach. On Behalf of ECMO-VAD Study Group

Author

Saeed, D., primary, Potapov, E.V., additional, Loforte, A., additional, Morshuis, M., additional, Schibilsky, D., additional, Zimpfer, D., additional, Riebandt, J., additional, Pappalardo, F., additional, Attisani, M., additional, Haneya, A., additional, Ramjankhan, F., additional, Donker, D., additional, Tsyganenko, D., additional, Jorde, U., additional, Jawad, K., additional, Wieloch, R., additional, Ayala, R., additional, Aspern, C., additional, Cremer, J., additional, Borger, M., additional, Lichtenberg, A., additional, and Gummert, J.F., additional

Published
2020
Full Text
View/download PDF

39. Transition from Short-Term to Durable Mechanical Circulatory Support Systems. Outcome and Patient Selection. On Behalf of ECMO-VAD Study Group

Author

Saeed, D., primary, Potapov, E., additional, Loforte, A., additional, Morchius, M., additional, Schibilsky, D., additional, Zimpfer, D., additional, Riebandt, J., additional, Pappalardo, F., additional, Attisani, M., additional, Haneya, A., additional, Ramjankhan, F., additional, Donker, D., additional, Jorde, U., additional, Wieloch, R., additional, Ayala, R., additional, Tsyganenko, D., additional, Cremer, J., additional, Lichtenberg, A., additional, and Gummert, J., additional

Published
2019
Full Text
View/download PDF

41. Transition from Short Term to Durable Mechanical Circulatory Support Systems. Outcome and Patient Selection. On Behalf of ECMO-VAD Study Group

Author

Saeed, D., additional, Potapov, E., additional, Loforte, A., additional, Morshuis, M., additional, Schibilsky, D., additional, Zimpfer, D., additional, Riebandt, J., additional, Pappalardo, F., additional, Attisani, M., additional, Haneya, A., additional, Ramjankhan, F., additional, Donker, D., additional, Tsyganenko, D., additional, Jorde, U., additional, Wieloch, R., additional, Cremer, J., additional, Beyersdorf, F., additional, Lichtenberg, A., additional, and Gummert, J., additional

Published
2019
Full Text
View/download PDF

43. Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement

Author

Circulatory Health, Team Medisch, Arts Assistenten Cardiologie, Cardiologie, CTC, Divisie Hart & Longen, Regenerative Medicine and Stem Cells, Jansen, R., Wind, A. M., Cramer, M. J., Nijhoff, F., Agostoni, P., Ramjankhan, F. Z., Suyker, W. J., Stella, P. R., Chamuleau, S. A. J., Circulatory Health, Team Medisch, Arts Assistenten Cardiologie, Cardiologie, CTC, Divisie Hart & Longen, Regenerative Medicine and Stem Cells, Jansen, R., Wind, A. M., Cramer, M. J., Nijhoff, F., Agostoni, P., Ramjankhan, F. Z., Suyker, W. J., Stella, P. R., and Chamuleau, S. A. J.

Published
2018

44. Extracorporeal life support in cardiogenic shock: Indications and management in current practice

Author

Planningssecretariaat HCK, Arts Assistenten Cardiologie, Perfusie, Circulatory Health, Medische staf Anesthesiologie, Other research (not in main researchprogram), Team Medisch, Fysiotherapiewetenschap, Medische Staf Intensive Care, Meuwese, C. L., Ramjankhan, F. Z., Braithwaite, S. A., De Jonge, N., De Jong, M., Buijsrogge, M. P., Janssen, J. G.D., Klöpping, C., Kirkels, J. H., Donker, D. W., Planningssecretariaat HCK, Arts Assistenten Cardiologie, Perfusie, Circulatory Health, Medische staf Anesthesiologie, Other research (not in main researchprogram), Team Medisch, Fysiotherapiewetenschap, Medische Staf Intensive Care, Meuwese, C. L., Ramjankhan, F. Z., Braithwaite, S. A., De Jonge, N., De Jong, M., Buijsrogge, M. P., Janssen, J. G.D., Klöpping, C., Kirkels, J. H., and Donker, D. W.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results